MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bray, P. G.
Right arrow Articles by Ward, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bray, P. G.
Right arrow Articles by Ward, S. A.

Vol. 54, Issue 1, 170-179, July 1998

Access to Hematin: The Basis of Chloroquine Resistance

Patrick G. Bray, Mathirut Mungthin, Robert G. Ridley, and Stephen A. Ward

Department of Pharmacology and Therapeutics (P.G.B., M.M., S.A.W.), The University of Liverpool, Liverpool L69 3BX, UK, and Hoffmann-La Roche (R.G.R.), Pharmaceuticals Division, Pharma Research Preclinical, CH-4070 Basel, Switzerland

The saturable uptake of chloroquine by parasites of Plasmodium falciparum has been attributed to specific carrier-mediated transport of chloroquine. It is suggested that chloroquine is transported in exchange for protons by the parasite membrane Na+/H+ exchanger [J Biol Chem 272:2652-2658 (1997)]. Once inside the parasite, it is proposed that chloroquine inhibits the polymerization of hematin, allowing this toxic hemoglobin metabolite to accumulate and kill the cell [Pharmacol Ther 57:203-235 (1993)]. To date, the contribution of these proposed mechanisms to the uptake and antimalarial activity of chloroquine has not been assessed. Using sodium-free medium, we demonstrate that chloroquine is not directly exchanged for protons by the plasmodial Na+/H+ exchanger. Furthermore, we show that saturable chloroquine uptake at equilibrium is due solely to the binding of chloroquine to hematin rather than active uptake: using Ro 40-4388, a potent and specific inhibitor of hemoglobin digestion and, by implication, hematin release, we demonstrate a concentration-dependent reduction in the number of chloroquine binding sites. An equal number of chloroquine binding sites are found in both resistant and susceptible clones, but the apparent affinity of chloroquine binding is found to correlate with drug activity (r2 = 0.93, p < 0.0001). This completely accounts for both the reduced drug accumulation and activity observed in resistant clones and the "reversal" of resistance produced by verapamil. The data presented here reconcile most of the available biochemical data from studies of the mode of action of chloroquine and the mechanism of chloroquine resistance. We show that the activity of chloroquine and amodiaquine is directly dependent on the saturable binding of the drugs to hematin and that the inhibition of hematin polymerization may be secondary to this binding. The chloroquine-resistance mechanism regulates the access of chloroquine to hematin. Our model is consistent with a resistance mechanism that acts specifically at the food vacuole to alter the binding of chloroquine to hematin rather than changing the active transport of chloroquine across the parasite plasma membrane.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
A. M. Lehane, R. Hayward, K. J. Saliba, and K. Kirk
A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites
J. Cell Sci., May 15, 2008; 121(10): 1624 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
Q. L. Fivelman, I. S. Adagu, and D. C. Warhurst
Effects of Piperaquine, Chloroquine, and Amodiaquine on Drug Uptake and of These in Combination with Dihydroartemisinin against Drug-Sensitive and -Resistant Plasmodium falciparum Strains
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2265 - 2267.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
C. T. HAPPI, G. O. GBOTOSHO, O. A. FOLARIN, O. M. BOLAJI, A. SOWUNMI, D. E. KYLE, W. MILHOUS, D. F. WIRTH, and A. M. J. ODUOLA
ASSOCIATION BETWEEN MUTATIONS IN PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER AND P. FALCIPARUM MULTIDRUG RESISTANCE 1 GENES AND IN VIVO AMODIAQUINE RESISTANCE IN P. FALCIPARUM MALARIA-INFECTED CHILDREN IN NIGERIA.
Am J Trop Med Hyg, July 1, 2006; 75(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Hayward, K. J. Saliba, and K. Kirk
The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance
J. Cell Sci., March 15, 2006; 119(6): 1016 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Hayward, K. J. Saliba, and K. Kirk
Mutations in pfmdr1 Modulate the Sensitivity of Plasmodium falciparum to the Intrinsic Antiplasmodial Activity of Verapamil
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 840 - 842.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. J. Vial, S. Wein, C. Farenc, C. Kocken, O. Nicolas, M. L. Ancelin, F. Bressolle, A. Thomas, and M. Calas
Prodrugs of bisthiazolium salts are orally potent antimalarials
PNAS, October 26, 2004; 101(43): 15458 - 15463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Nessler, O. Friedrich, N. Bakouh, R. H. A. Fink, C. P. Sanchez, G. Planelles, and M. Lanzer
Evidence for Activation of Endogenous Transporters in Xenopus laevis Oocytes Expressing the Plasmodium falciparum Chloroquine Resistance Transporter, PfCRT
J. Biol. Chem., September 17, 2004; 279(38): 39438 - 39446.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
P. Winstanley, S. Ward, R. Snow, and A. Breckenridge
Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to Policy
Clin. Microbiol. Rev., July 1, 2004; 17(3): 612 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Waller, R. A. Muhle, L. M. Ursos, P. Horrocks, D. Verdier-Pinard, A. B. S. Sidhu, H. Fujioka, P. D. Roepe, and D. A. Fidock
Chloroquine Resistance Modulated in Vitro by Expression Levels of the Plasmodium falciparum Chloroquine Resistance Transporter
J. Biol. Chem., August 29, 2003; 278(35): 33593 - 33601.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
E. O. OCHONG', I. V. F. VAN DEN BROEK, K. KEUS, and A. NZILA
SHORT REPORT: ASSOCIATION BETWEEN CHLOROQUINE AND AMODIAQUINE RESISTANCE AND ALLELIC VARIATION IN THE PLASMODIUM FALCIPARUM MULTIPLE DRUG RESISTANCE 1 GENE AND THE CHLOROQUINE RESISTANCE TRANSPORTER GENE IN ISOLATES FROM THE UPPER NILE IN SOUTHERN SUDAN
Am J Trop Med Hyg, August 1, 2003; 69(2): 184 - 187.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. B. S. Sidhu, D. Verdier-Pinard, and D. A. Fidock
Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations
Science, October 4, 2002; 298(5591): 210 - 213.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K. Wengelnik, V. Vidal, M. L. Ancelin, A.-M. Cathiard, J. L. Morgat, C. H. Kocken, M. Calas, S. Herrera, A. W. Thomas, and H. J. Vial
A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes
Science, February 15, 2002; 295(5558): 1311 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Cooper, M. T. Ferdig, X.-Z. Su, L. M. B. Ursos, J. Mu, T. Nomura, H. Fujioka, D. A. Fidock, P. D. Roepe, and T. E. Wellems
Alternative Mutations at Position 76 of the Vacuolar Transmembrane Protein PfCRT Are Associated with Chloroquine Resistance and Unique Stereospecific Quinine and Quinidine Responses in Plasmodium falciparum
Mol. Pharmacol., January 1, 2002; 61(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. K. Mehlotra, H. Fujioka, P. D. Roepe, O. Janneh, L. M. B. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, et al.
Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America
PNAS, October 23, 2001; 98(22): 12689 - 12694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. W. Stead, P. G. Bray, I. G. Edwards, H. P. DeKoning, B. C. Elford, P. A. Stocks, and S. A. Ward
Diamidine Compounds: Selective Uptake and Targeting in Plasmodium falciparum
Mol. Pharmacol., April 16, 2001; 59(5): 1298 - 1306.
[Abstract] [Full Text]


Home page
NEJMHome page
A. Djimde, O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X.-z. Su, T. Nomura, D. A. Fidock, et al.
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria
N. Engl. J. Med., January 25, 2001; 344(4): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
Y. Kurosawa, A. Dorn, M. Kitsuji-Shirane, H. Shimada, T. Satoh, H. Matile, W. Hofheinz, R. Masciadri, M. Kansy, and R. G. Ridley
Hematin Polymerization Assay as a High-Throughput Screen for Identification of New Antimalarial Pharmacophores
Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2638 - 2644.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
K. Haruki, P. G. Bray, M. Ono, and S. A. Ward
Potent Enhancement of the Sensitivity of Plasmodium falciparum to Chloroquine by the Bisbenzylisoquinoline Alkaloid Cepharanthin
Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2706 - 2708.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
I. Crandall, J. Charuk, and K. C. Kain
Nonylphenolethoxylates as Malarial Chloroquine Resistance Reversal Agents
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2431 - 2434.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. J. Saliba and K. Kirk
pH Regulation in the Intracellular Malaria Parasite, Plasmodium falciparum. H+ EXTRUSION VIA A V-TYPE H+-ATPase
J. Biol. Chem., November 19, 1999; 274(47): 33213 - 33219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Pandey, B. L. Tekwani, R. L. Singh, and V. S. Chauhan
Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite
J. Biol. Chem., July 2, 1999; 274(27): 19383 - 19388.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
P. G. Bray, O. Janneh, K. J. Raynes, M. Mungthin, H. Ginsburg, and S. A. Ward
Cellular Uptake of Chloroquine Is Dependent on Binding to Ferriprotoporphyrin IX and Is Independent of NHE Activity in Plasmodium falciparum
J. Cell Biol., April 19, 1999; 145(2): 363 - 376.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Mungthin, P. G. Bray, R. G. Ridley, and S. A. Ward
Central Role of Hemoglobin Degradation in Mechanisms of Action of 4-Aminoquinolines, Quinoline Methanols, and Phenanthrene Methanols
Antimicrob. Agents Chemother., November 1, 1998; 42(11): 2973 - 2977.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics